| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.26 | 7e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.25 | 7e-05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0003 |